BDBM134226 US8846673, 96
SMILES: CS(=O)(=O)Nc1ccc(cc1)-c1ncc(-c2ccc(Oc3ccccc3)cc2)c2c(N)n[nH]c12
InChI Key: InChIKey=RMNHYPZVNFTHCB-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM134226 (US8846673, 96) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 280 | n/a | n/a | n/a | n/a | 7.4 | 0 |
Bristol-Myers Squibb Company US Patent | Assay Description To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 uM), ATP (2... | US Patent US8846673 (2014) BindingDB Entry DOI: 10.7270/Q26M35HM | |||||||||||
More data for this Ligand-Target Pair |